Search Within

Nitya Prabhakar Raj

  1. "Heiko Schoder"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Center for Pancreatic Cancer Research (6)
  2. Department of Medicine (6)
  3. Gastrointestinal Oncology Service (6)
  4. Molecular Imaging and Therapy Service (6)
  5. Radiology, Department of (6)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. Diane Reidy (6)
  2. Heiko Schoder (6)
  3. Lisa Bodei (6)
  4. Kinh Gian Do (4)
  5. Christopher Riedl (3)
  6. Joanne Chou (3)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (2)
Publications
  1. Journal of Nuclear Medicine (2)
  2. Pancreas (2)
  3. Journal of Clinical Oncology (1)
  4. Neuroendocrinology (1)
Publishers
  1. Lippincott Williams & Wilkins (2)
  2. Society of Nuclear Medicine (2)
  3. American Society of Clinical Oncology (1)
  4. S. Karger AG (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schòˆder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to lutetium-177-DOTATATE
    Journal Article

    Raj, N.; Coffman, K.; Le, T.; Do, R. K. G.; Rafailov, J.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; more...
    Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schòˆder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE
    Meeting Abstract

    Coffman, K. L.; Bodei, L.; Le, T.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; Grewal, R. K.; Reddy, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save